Incidence of pediatric multiple sclerosis in Iran from 2000 to 2019
Iranian Journal of Child Neurology,
Vol. 16 No. 1 (2022),
1 January 2022
,
Page 31-38
https://doi.org/10.22037/ijcn.v16i1.35572
Abstract
Objectives
Due to a lack of data on pediatric multiple sclerosis (MS) epidemiology in Iran, this study aimed to determine the incidence rate of pediatric MS in Iran.
Materials & Methods
All the data of the patients with MS registered in the Ministry of Health and Medical Education of Iran for 20 years were collected in this study; therefor; those born in 1982 and diagnosed with the disease and treated since 2000 were included in this study. The collected variables were patients’ age at the time of diagnosis, gender, year of diagnosis, urban or rural residency, and province of residence. Additionally, agespecific incidence rates per 100,000 of the population were calculated.
Results
This study was performed on 4544 cases of pediatric MS within 2000- 2019, of which 997 patients (21.9%) were male. The mean age of the patients with MS at the time of diagnosis was 14.3±4.6 years, and 4414 children (97.1%) lived in urban areas. The incidence rate of pediatric MS in Iran during 20 years increased from 0.26 per 100,000 of the population in 2000 to 1.53 in 2019.
Conclusion
The incidence of pediatric MS in Iran is high, and the development of diagnostic practices in the past decade in Iran has contributed to the detection of this high incidence.
- Incidence, pediatric MS, Epidemiology
How to Cite
References
Correale J, Marrodan M, Ysrraelit MC. Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis. Biomedicines. 2019; 7(1):14.
Alroughani R, Boyko A. Pediatric multiple sclerosis: a review. BMC Neurol. 2018; 18(1):27.
Jeong A, Oleske DM, Holman J. Epidemiology of Pediatric-Onset Multiple Sclerosis: A Systematic Review of the Literature. J Child Neurol 2019; 34(12):705-712.
Boiko A, Vorobeychik G, Paty D, Devonshire V, Sadovnick D. Early onset multiple sclerosis: a longitudinal study. Neurology 2002; 59(7):1006-10.
Bigi S, Banwell B. Pediatric multiple sclerosis. J Child Neurol 2012; 27(11):1378-83.
Gadoth N. Multiple sclerosis in children. Brain Dev 2003; 25(4):229-32.
O'Gorman C, Lucas R, Taylor B. Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. Int J Mol Sci. 2012;13(9):11718-52.
Amato MP, Goretti B, Ghezzi A, Lori S, Zipoli V, Portaccio E, et al. Cognitive and psychosocial features of childhood and juvenile MS. Neurology 2008; 70(20):1891-7.
Amato MP, Goretti B, Ghezzi A, Lori S, Zipoli V, Moiola L, et al. Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. Neurology 2010; 75(13):1134-40.
Goretti B, Portaccio E, Ghezzi A, Lori S, Moiola L, Falautano M, et al. Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosis. Mult Scler 2012; 18(3):329-34.
Ketelslegers IA, Catsman-Berrevoets CE, Boon M, Eikelenboom MJ, Stroink H, Neuteboom RF, et al. Fatigue and depression in children with multiple sclerosis and monophasic variants. Eur J Paediatr Neurol 2010; 14(4):320-5.
MacAllister WS, Christodoulou C, Troxell R, Milazzo M, Block P, Preston TE, et al. Fatigue and quality of life in pediatric multiple sclerosis. Mult Scler 2009; 15(12):1502-8.
Carroll S, Chalder T, Hemingway C, Heyman I, Moss-Morris R. Understanding fatigue in paediatric multiple sclerosis: a systematic review of clinical and psychosocial factors. Dev Med Child Neurol 2016; 58(3):229-39.
MacAllister WS, Belman AL, Milazzo M, Weisbrot DM, Christodoulou C, Scherl WF, et al. Cognitive functioning in children and adolescents with multiple sclerosis. Neurology 2005; 64(8):1422-5.
Banwell BL, Anderson PE. The cognitive burden of multiple sclerosis in children. Neurology 2005; 64(5):891-4.
MacAllister WS, Boyd JR, Holland NJ, Milazzo MC, Krupp LB. The psychosocial consequences of pediatric multiple sclerosis. Neurology 2007; 68(16 Suppl 2):S66-9.
Amato MP, Goretti B, Ghezzi A, Hakiki B, Niccolai C, Lori S, et al. Neuropsychological features in childhood and juvenile multiple sclerosis: five-year follow-up. Neurology 2014; 83(16):1432-8.
Cardoso M, Olmo NR, Fragoso YD. Systematic Review of Cognitive Dysfunction in Pediatric and Juvenile Multiple Sclerosis. Pediatr Neurol 2015; 53(4):287-92.
Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC, et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 2013; 19(10):1261-7.
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018; 17(2):162-173.
Langer-Gould A, Zhang JL, Chung J, Yeung Y, Waubant E, Yao J. Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children. Neurology. 2011; 77(12):1143-8.
Alroughani R, Ahmed SF, Al-Hashel J. Pediatric-Onset Multiple Sclerosis Disease Progression in Kuwait: A Retrospective Analysis. Pediatr Neurol. 2015; 53(6):508-12.
Dell'Avvento S, Sotgiu MA, Manca S, Sotgiu G, Sotgiu S. Epidemiology of multiple sclerosis in the pediatric population of Sardinia, Italy. Eur J Pediatr. 2016;175(1):19-29.
Reinhardt K, Weiss S, Rosenbauer J, Gärtner J, von Kries R. Multiple sclerosis in children and adolescents: incidence and clinical picture - new insights from the nationwide German surveillance (2009-2011). Eur J Neurol. 2014; 21(4):654-9.
Ford H. Clinical presentation and diagnosis of multiple sclerosis. Clin Med (Lond). 2020; 20(4):380-383.
Pena JA, Lotze TE. Pediatric multiple sclerosis: current concepts and consensus definitions. Autoimmune Dis. 2013;2013:673947.
Renoux C, Vukusic S, Mikaeloff Y, Edan G, Clanet M, Dubois B, et al. Natural history of multiple sclerosis with childhood onset. N Engl J Med 2007; 356(25):2603-13.
Moghaddam VK, Dickerson AS, Bazrafshan E, Seyedhasani SN, Najafi F, Hadei M, et al. Socioeconomic determinants of global distribution of multiple sclerosis: an ecological investigation based on Global Burden of Disease data. BMC Neurol. 2021; 21(1):145.
Neisi A. A survey on the human development index in the Provinces of Iran. Jundishapur J Health Sci 2010; 2: 55-62.
- Abstract Viewed: 487 times